Mayo Clinic Q&A: COVID-19 Vaccine Trials Update

Everyone
  • 1 video | 19m 19s
Rating 4.3 of 13 users Rating 4.3 of 13 users (13)
While the number of COVID-19 cases continues to surge, there is positive news on the vaccine front. In early clinical trial data, two vaccines have now shown at least 90% effectiveness in reducing the risk of infection from the virus that causes COVID-19. While more time and research is needed to understand how long the immunity from a vaccine lasts, experts believe a vaccine could be approved for emergency use authorization before the end of the year. (Published 11/17/2020)

YOU MIGHT ALSO LIKE

Course Mayo Clinic Q&A: Tackling the Latest COVID-19 Topics
Rating 4.6 of 37 users Rating 4.6 of 37 users (37)
Course Mayo Clinic Q&A: FDA Sets Stricter Standards for COVID-19 Vaccine Development
Rating 4.5 of 8 users Rating 4.5 of 8 users (8)
Course Mayo Clinic Q&A: The Latest on COVID-19
Rating 4.4 of 128 users Rating 4.4 of 128 users (128)

PEOPLE WHO VIEWED THIS ALSO VIEWED THESE

Course Mayo Clinic Q&A: Rapid pace of COVID-19 vaccinations
Rating 4.6 of 37 users Rating 4.6 of 37 users (37)
Course Mayo Clinic Q&A: Innovation is Transforming Patient Care in Florida, Beyond
Rating 4.8 of 13 users Rating 4.8 of 13 users (13)
Course Mayo Clinic Q&A: Don't Hesitate, Dive into Data for COVID-19 Vaccine
Rating 4.4 of 8 users Rating 4.4 of 8 users (8)